{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:28Z","timestamp":1793395648290,"version":"4.5.0"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31820103004"],"award-info":[{"award-number":["31820103004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31730032"],"award-info":[{"award-number":["31730032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["YSBR-036"],"award-info":[{"award-number":["YSBR-036"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB36000000"],"award-info":[{"award-number":["XDB36000000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["JCTD-2020-04"],"award-info":[{"award-number":["JCTD-2020-04"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0208900"],"award-info":[{"award-number":["2018YFA0208900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jconrel.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T17:41:46Z","timestamp":1720978906000},"page":"128-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery"],"prefix":"10.1016","volume":"373","author":[{"given":"Ammara","family":"Safdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Muhaymin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.07.013_bb0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","article-title":"Cell membrane coated nanocarriers-an efficient biomimetic platform for targeted therapy","volume":"327","author":"Dash","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0010","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/1567201813666160713121122","article-title":"Nanoparticles for cancer targeting: current and future directions","volume":"13","author":"Swain","year":"2016","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1039\/D0CS00986E","article-title":"Approaches for the inhibition and elimination of microbial biofilms using macromolecular agents","volume":"50","author":"Blackman","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nnano.2008.34","article-title":"Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications","volume":"3","author":"Tasciotti","year":"2008","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2011.10.021","article-title":"Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution","volume":"158","author":"Van De Ven","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/10717544.2021.1938757","article-title":"Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0040","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1039\/D0BM00029A","article-title":"Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer","volume":"8","author":"Li","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biomaterials.2016.10.003","article-title":"Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia","volume":"111","author":"Wei","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0050","doi-asserted-by":"crossref","first-page":"2101349","DOI":"10.1002\/adhm.202101349","article-title":"White blood cell membrane-coated nanoparticles: recent development and medical applications","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0055","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3390\/cancers11121836","article-title":"Cancer cell membrane-coated nanoparticles for cancer management","volume":"11","author":"Harris","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0060","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1039\/D0BM01164A","article-title":"Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0065","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/acs.biomac.1c00440","article-title":"Hybrid membrane-coated biomimetic nanoparticles (HM@ BNPs): a multifunctional nanomaterial for biomedical applications","volume":"22","author":"Zhao","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121297","article-title":"Biomimetic nanoparticles: U937 cell membranes based core\u2013shell nanosystems for targeted atherosclerosis therapy","volume":"611","author":"Shen","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0075","doi-asserted-by":"crossref","first-page":"1700270","DOI":"10.1002\/smtd.201700270","article-title":"Red blood cells for drug delivery","volume":"1","author":"Yan","year":"2017","journal-title":"Small Methods"},{"issue":"13","key":"10.1016\/j.jconrel.2024.07.013_bb0080","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1039\/C5NR07588B","article-title":"Monocyte cell membrane-derived nanoghosts for targeted cancer therapy","volume":"8","author":"Krishnamurthy","year":"2016","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0085","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","article-title":"Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation","volume":"143","author":"Jurasz","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1160\/TH11-08-0592","article-title":"Platelets in atherosclerosis","volume":"106","author":"Lievens","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrmicro1425","article-title":"The interaction of bacterial pathogens with platelets","volume":"4","author":"Fitzgerald","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.013_bb0100","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2004-04-1365","article-title":"The platelet glycoprotein Ib\u2013von Willebrand factor interaction activates the collagen receptor \u03b12\u03b21 to bind collagen: activation-dependent conformational change of the \u03b12-I domain","volume":"105","author":"Cruz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6138145","article-title":"The interaction of selectins and PSGL-1 as a key component in thrombus formation and cancer progression","volume":"2017","author":"Kappelmayer","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0110","first-page":"509","article-title":"A role for glycoprotein Ib in Streptococcus sanguis\u2013induced platelet aggregation","volume":"100","author":"Kerrigan","year":"2002","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm973","article-title":"Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis","volume":"10","author":"Avecilla","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-94-1-108","article-title":"Platelets and their membranes in hemostasis: physiology and pathophysiology","volume":"94","author":"Shattil","year":"1981","journal-title":"Ann. Intern. Med."},{"issue":"16","key":"10.1016\/j.jconrel.2024.07.013_bb0125","first-page":"1877","article-title":"Regulating billions of blood platelets: glycans and beyond","volume":"126","author":"Grozovsky","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0130","series-title":"Seminars in Hematology","article-title":"The platelet fibrinogen receptor","author":"Peerschke","year":"1985"},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0135","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3324\/haematol.2014.116863","article-title":"Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow","volume":"100","author":"Swieringa","year":"2015","journal-title":"haematologica"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"van der Meijden","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/781857","article-title":"Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis","volume":"2014","author":"Ghoshal","year":"2014","journal-title":"Sci. World J."},{"issue":"03","key":"10.1016\/j.jconrel.2024.07.013_bb0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1160\/TH07-12-0718","article-title":"Platelet GPIb complex as a target for anti-thrombotic drug development","volume":"99","author":"Clemetson","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0160","series-title":"Seminars in Hematology","article-title":"The molecular biology of platelet membrane proteins","author":"Bennett","year":"1990"},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0165","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jth.13613","article-title":"Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets","volume":"15","author":"Poulter","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1538-7836.2007.02871.x","article-title":"MMP-2 regulates human platelet activation by interacting with integrin \u03b1IIb\u03b23","volume":"6","author":"Choi","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0175","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20021868","article-title":"Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin","volume":"197","author":"Falati","year":"2003","journal-title":"J. Exp. Med."},{"issue":"15","key":"10.1016\/j.jconrel.2024.07.013_bb0180","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1016\/S0021-9258(17)42770-0","article-title":"A monoclonal antibody to a membrane glycoprotein binds only to activated platelets","volume":"259","author":"McEver","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"07","key":"10.1016\/j.jconrel.2024.07.013_bb0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0037-1616220","article-title":"ADP receptors of platelets and their inhibition","volume":"86","author":"Gachet","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0014-5793(94)00355-6","article-title":"Cloning and expression of a cDNA for the human prostacyclin receptor","volume":"344","author":"Katsuyama","year":"1994","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/bj2910157","article-title":"Regulation of the receptor for platelet-activating factor on human platelets","volume":"291","author":"Burgers","year":"1993","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.013_bb0200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thromres.2004.06.046","article-title":"Platelet glycoprotein VI: its structure and function","volume":"114","author":"Moroi","year":"2004","journal-title":"Thromb. Res."},{"issue":"38","key":"10.1016\/j.jconrel.2024.07.013_bb0210","doi-asserted-by":"crossref","first-page":"36748","DOI":"10.1074\/jbc.M300702200","article-title":"CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells","volume":"278","author":"Kojima","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0215","first-page":"2600","volume":"95","author":"Sobocka","year":"2000","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0220","first-page":"2351","article-title":"Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56lck","volume":"97","author":"Newman","year":"2001","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0225","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2004-01-0315","article-title":"A TREM family member, TLT-1, is found exclusively in the \u03b1-granules of megakaryocytes and platelets","volume":"104","author":"Washington","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0230","first-page":"981","article-title":"Historical review: megakaryopoiesis and thrombopoiesis","volume":"111","author":"Kaushansky","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0235","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.48.2.426","article-title":"Leptin promotes aggregation of human platelets via the long form of its receptor","volume":"48","author":"Nakata","year":"1999","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0240","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009100","article-title":"Structural and functional properties of platelet-derived growth factor and stem cell factor receptors","volume":"5","author":"Heldin","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6868","key":"10.1016\/j.jconrel.2024.07.013_bb0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/415175a","article-title":"Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface","volume":"415","author":"Dale","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0250","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","article-title":"Cellular fatty acid uptake: a pathway under construction","volume":"20","author":"Su","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0255","doi-asserted-by":"crossref","first-page":"2302074","DOI":"10.1002\/adhm.202302074","article-title":"Biomimetic platelet-cloaked nanoparticles for the delivery of anti-inflammatory curcumin in the treatment of atherosclerosis","author":"Fontana","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0171-2985(98)80030-2","article-title":"Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis","volume":"199","author":"Peerschke","year":"1998","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.013_bb0265","first-page":"378","article-title":"Lysosomal membrane glycoproteins in platelets","volume":"68","author":"Metzelaar","year":"1992","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0270","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.CIR.0000027107.54614.1A","article-title":"CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species","volume":"106","author":"Urbich","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120395","article-title":"Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy","volume":"598","author":"Kunde","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0280","doi-asserted-by":"crossref","first-page":"0011","DOI":"10.1038\/s41551-016-0011","article-title":"In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy","volume":"1","author":"Wang","year":"2017","journal-title":"Nat. Biomed. Eng."},{"issue":"43","key":"10.1016\/j.jconrel.2024.07.013_bb0285","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1002\/adma.201603463","article-title":"Engineered nanoplatelets for enhanced treatment of multiple myeloma and thrombus","volume":"28","author":"Hu","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0295","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.4049\/jimmunol.175.7.4450","article-title":"Binding of IgG-opsonized particles to Fc\u03b3R is an active stage of phagocytosis that involves receptor clustering and phosphorylation","volume":"175","author":"Sobota","year":"2005","journal-title":"J. Immunol."},{"issue":"7571","key":"10.1016\/j.jconrel.2024.07.013_bb0300","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.013_bb0305","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2004-08-2980","article-title":"Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia","volume":"105","author":"Olsson","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0310","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.4049\/jimmunol.1601943","article-title":"Overexpression of human CD55 and CD59 or treatment with human CD55 protects against renal ischemia-reperfusion injury in mice","volume":"198","author":"Bongoni","year":"2017","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2024.07.013_bb0315","doi-asserted-by":"crossref","first-page":"2100787","DOI":"10.1002\/advs.202100787","article-title":"Platelet-like fusogenic liposome-mediated targeting delivery of mir-21 improves myocardial remodeling by reprogramming macrophages post myocardial ischemia-reperfusion injury","volume":"8","author":"Tan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jconrel.2020.05.016","article-title":"Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy","volume":"324","author":"Mei","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0669-2","article-title":"Role of platelets and platelet receptors in cancer metastasis","volume":"11","author":"Schlesinger","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0330","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3389\/fonc.2020.01350","article-title":"Platelets and metastasis: new implications of an old interplay","volume":"10","author":"Lucotti","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0335","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.celrep.2018.03.092","article-title":"Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration","volume":"23","author":"Ward","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0340","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10585-019-10009-y","article-title":"The contribution of platelets to intravascular arrest, extravasation, and outgrowth of disseminated tumor cells","volume":"37","author":"Foss","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0345","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11684-017-0583-y","article-title":"Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy","volume":"12","author":"Zhang","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0350","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1538-7836.2011.04361.x","article-title":"Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke","volume":"9","author":"Nieswandt","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/09537101003695339","article-title":"GPIb\u03b1-selective activation of platelets induces platelet signaling events comparable to GPVI activation events","volume":"21","author":"Gardiner","year":"2010","journal-title":"Platelets"},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.013_bb0360","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0365","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10237-011-0301-7","article-title":"Experimental measurement of dynamic fluid shear stress on the aortic surface of the aortic valve leaflet","volume":"11","author":"Yap","year":"2012","journal-title":"Biomech. Model. Mechanobiol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0370","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2958.2005.04942.x","article-title":"Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase","volume":"59","author":"Naito","year":"2006","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0375","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/IAI.00664-09","article-title":"Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa","volume":"78","author":"Petersen","year":"2010","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0380","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1128\/IAI.01794-05","article-title":"gC1qR\/p33 blockade reduces Staphylococcus aureus colonization of target tissues in an animal model of infective endocarditis","volume":"74","author":"Peerschke","year":"2006","journal-title":"Infect. Immun."},{"issue":"21","key":"10.1016\/j.jconrel.2024.07.013_bb0385","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1111\/j.1742-4658.2006.05482.x","article-title":"Staphylococcus aureus protein a binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions","volume":"273","author":"O\u2019Seaghdha","year":"2006","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0390","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.eng.2020.09.013","article-title":"Engineered biomimetic platelet membrane-coated nanoparticles block Staphylococcus aureus cytotoxicity and protect against lethal systemic infection","volume":"7","author":"Kim","year":"2021","journal-title":"Engineering"},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.013_bb0395","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/polym10090983","article-title":"Cell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics","volume":"10","author":"Vijayan","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0400","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-981-13-0445-3_3","article-title":"Cell membrane coated nanoparticles: an emerging biomimetic nanoplatform for targeted bioimaging and therapy","author":"Vijayan","year":"2018","journal-title":"Biomimetic Medical Materials"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-22311-z","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Bahmani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0410","doi-asserted-by":"crossref","first-page":"724525","DOI":"10.3389\/fphar.2021.724525","article-title":"Berberine-loaded biomimetic nanoparticles attenuate inflammation of experimental allergic asthma via enhancing IL-12 expression","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.013_bb0415","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.7150\/thno.20118","article-title":"Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy","volume":"7","author":"Zhai","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110298","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: a review","volume":"106","author":"He","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"issue":"27","key":"10.1016\/j.jconrel.2024.07.013_bb0425","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0430","doi-asserted-by":"crossref","first-page":"1604300","DOI":"10.1002\/adfm.201604300","article-title":"Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer","volume":"27","author":"Sun","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","article-title":"Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy","volume":"105","author":"Xu","year":"2020","journal-title":"Acta Biomater."},{"issue":"21","key":"10.1016\/j.jconrel.2024.07.013_bb0440","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1039\/D0TB00735H","article-title":"Platelet membrane-coated nanoparticles for targeted drug delivery and local chemo-photothermal therapy of orthotopic hepatocellular carcinoma","volume":"8","author":"Wu","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.013_bb0445","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1039\/D0NR08492A","article-title":"Single-particle fibrinogen detection using platelet membrane-coated fluorescent polystyrene nanoparticles","volume":"13","author":"Chen","year":"2021","journal-title":"Nanoscale"},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0450","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/cancers11060807","article-title":"The delivery strategy of paclitaxel nanostructured lipid carrier coated with platelet membrane","volume":"11","author":"Bang","year":"2019","journal-title":"Cancers"},{"issue":"37","key":"10.1016\/j.jconrel.2024.07.013_bb0455","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0460","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0465","doi-asserted-by":"crossref","first-page":"14815","DOI":"10.1038\/s41598-018-33107-5","article-title":"Determination of the main phase transition temperature of phospholipids by nanoplasmonic sensing","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0470","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1038\/s41598-021-03422-5","article-title":"Optimization of critical parameters for coating of polymeric nanoparticles with plasma membrane vesicles by sonication","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0475","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.nanolett.1c00168","article-title":"Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0480","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acsnano.7b07720","article-title":"Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis","volume":"12","author":"Wei","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0485","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1039\/D0BM02125C","article-title":"Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy","volume":"9","author":"Zhao","year":"2021","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.013_bb0490","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Xu","year":"2019","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.jconrel.2024.07.013_bb0495","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0500","doi-asserted-by":"crossref","first-page":"1803567","DOI":"10.1002\/adfm.201803567","article-title":"Platelet-inspired nanocells for targeted heart repair after ischemia\/reperfusion injury","volume":"29","author":"Su","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0505","doi-asserted-by":"crossref","first-page":"1970019","DOI":"10.1002\/adfm.201970019","article-title":"Biomimetics: platelet-inspired nanocells for targeted heart repair after ischemia\/reperfusion injury (Adv. Funct. Mater. 4\/2019)","volume":"29","author":"Su","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-019-4580-8","article-title":"Docetaxel-loaded biomimetic nanoparticles for targeted lung cancer therapy in vivo","volume":"21","author":"Chi","year":"2019","journal-title":"J. Nanopart. Res."},{"issue":"22","key":"10.1016\/j.jconrel.2024.07.013_bb0515","doi-asserted-by":"crossref","first-page":"25635","DOI":"10.1021\/acsami.1c02581","article-title":"Platelet membrane-coated and VAR2CSA malaria protein-functionalized nanoparticles for targeted treatment of primary and metastatic Cancer","volume":"13","author":"Zhou","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0520","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/acsbiomaterials.1c00912","article-title":"Biomimetic platform based on mesoporous platinum for multisynergistic Cancer therapy","volume":"7","author":"Zhao","year":"2021","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.132328","article-title":"Proof of concept for dual anticancer effects by a novel nanomaterial-mediated cancer cell killing and nano-radiosensitization","volume":"429","author":"Duo","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0530","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1021\/acsbiomaterials.8b00979","article-title":"Platelet-mimic uPA delivery nanovectors based on au rods for thrombus targeting and treatment","volume":"4","author":"Yang","year":"2018","journal-title":"ACS Biomater Sci. Eng."},{"issue":"13","key":"10.1016\/j.jconrel.2024.07.013_bb0535","doi-asserted-by":"crossref","first-page":"eaaz6108","DOI":"10.1126\/sciadv.aaz6108","article-title":"Targeted gene silencing in vivo by platelet membrane\u2013coated metal-organic framework nanoparticles","volume":"6","author":"Zhuang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0540","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jconrel.2021.08.025","article-title":"Biomimetic, ROS-detonable nanoclusters\u2014a multimodal nanoplatform for anti-restenotic therapy","volume":"338","author":"Zhao","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01130-w","article-title":"Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing","volume":"19","author":"Peng","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.013_bb0550","doi-asserted-by":"crossref","first-page":"1604774","DOI":"10.1002\/adfm.201604774","article-title":"Antitumor platelet-mimicking magnetic nanoparticles","volume":"27","author":"Rao","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0555","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0560","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","article-title":"Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression","volume":"125","author":"L\u00fc\u00f6nd","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0565","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41571-018-0134-8","article-title":"A framework for the development of effective anti-metastatic agents","volume":"16","author":"Anderson","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0570","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0575","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0580","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201811","article-title":"LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy","volume":"218","author":"Sharma","year":"2021","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0585","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1038\/s41598-017-07168-x","article-title":"Lower mean platelet volume predicts poor prognosis in renal cell carcinoma","volume":"7","author":"Yun","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0590","first-page":"227","article-title":"Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer","volume":"25","author":"Sakin","year":"2020","journal-title":"J. BUON"},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0595","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cancers10110441","article-title":"Impacts of cancer on platelet production, activation and education and mechanisms of cancer-associated thrombosis","volume":"10","author":"Plantureux","year":"2018","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0600","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.jconrel.2024.07.013_bb0605","first-page":"4869","article-title":"Platelets increase the proliferation of ovarian cancer cells","volume":"120","author":"Cho","year":"2012","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0610","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0615","doi-asserted-by":"crossref","first-page":"eaai7911","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0620","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1021\/acsami.0c19259","article-title":"Biomimetic \u201cNanoplatelets\u201d as a targeted drug delivery platform for breast cancer theranostics","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0625","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1021\/acs.molpharmaceut.3c00310","article-title":"Enhanced antitumor efficacy of novel biomimetic platelet membrane-coated Tetrandrine nanoparticles in nonsmall cell lung Cancer","volume":"20","author":"Jiang","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124093","article-title":"Cisplatin-loaded mesoporous polydopamine nanoparticles capped with MnO2 and coated with platelet membrane provide synergistic anti-tumor therapy","volume":"656","author":"Zhang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0635","doi-asserted-by":"crossref","first-page":"2400919","DOI":"10.1002\/smll.202400919","article-title":"Platelet membrane coated Cu9S8-SNAP for targeting NIR-II mild photothermal enhanced chemodynamic\/gas therapy of triple-negative breast cancer","author":"Wu","year":"2024","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0640","first-page":"1378","article-title":"Clinical outcomes and experience of a multiyear consecutive case series of total knee arthroplasty procedures conducted with a bipolar sealer system for hemostasis","volume":"35","author":"Sah","year":"2021","journal-title":"J. Knee Surg."},{"issue":"13","key":"10.1016\/j.jconrel.2024.07.013_bb0645","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.3390\/molecules28135264","article-title":"Hemostasis strategies and recent advances in nanomaterials for hemostasis","volume":"28","author":"Du","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0650","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijbiomac.2020.03.170","article-title":"Hemostatic, biocompatible, and antibacterial non-animal fungal mushroom-based carboxymethyl chitosan-ZnO nanocomposite for wound-healing applications","volume":"155","author":"Rao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2024.07.013_bb0655","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.21037\/cdt.2017.08.07","article-title":"Hemostasis and nanotechnology","volume":"7","author":"Hangge","year":"2017","journal-title":"Cardiovasc. Diagnosis Ther."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0660","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fcvm.2021.707529","article-title":"Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms","volume":"8","author":"Malekmohammad","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0665","first-page":"1415","article-title":"Platelets and von Willebrand factor in atherogenesis","volume":"129","author":"Wu","year":"2017","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"03","key":"10.1016\/j.jconrel.2024.07.013_bb0670","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1160\/TH07-11-0685","article-title":"Platelet-vessel wall interactions in atherosclerotic disease","volume":"99","author":"Langer","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0675","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acsami.5b10950","article-title":"Platelet lysate-modified porous silicon microparticles for enhanced cell proliferation in wound healing applications","volume":"8","author":"Fontana","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0680","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/ATVBAHA.110.207480","article-title":"Platelet\u2013leukocyte interactions in cardiovascular disease and beyond","volume":"30","author":"Totani","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0685","doi-asserted-by":"crossref","first-page":"2000018","DOI":"10.1002\/sstr.202000018","article-title":"Drug targeting via platelet membrane\u2013coated nanoparticles","volume":"1","author":"Wang","year":"2020","journal-title":"Small Struct."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112464","article-title":"Platelet membrane-cloaked selenium\/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy","volume":"214","author":"Yin","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0695","doi-asserted-by":"crossref","DOI":"10.34133\/2022\/9845459","article-title":"Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy","author":"Chen","year":"2022","journal-title":"Research"},{"issue":"26","key":"10.1016\/j.jconrel.2024.07.013_bb0700","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1039\/D0TB00789G","article-title":"Platelet-derived nanomotor coated balloon for atherosclerosis combination therapy","volume":"8","author":"Huang","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0705","doi-asserted-by":"crossref","first-page":"2205260","DOI":"10.1002\/smll.202205260","article-title":"Platelet membrane cloaked nanotubes to accelerate thrombolysis by Thrombus clot-targeting and penetration","volume":"19","author":"Liu","year":"2023","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0710","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvt115","article-title":"Biological responses in stented arteries","volume":"99","author":"Chaabane","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0715","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0720","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.biomaterials.2018.06.025","article-title":"A paradigm of endothelium-protective and stent-free anti-restenotic therapy using biomimetic nanoclusters","volume":"178","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0725","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.2147\/IJN.S423186","article-title":"Glycosylation-engineered platelet membrane-coated interleukin 10 nanoparticles for targeted inhibition of vascular restenosis","author":"Li","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0730","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2014from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0735","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12951-022-01445-2","article-title":"Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"27","key":"10.1016\/j.jconrel.2024.07.013_bb0740","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1002\/ange.201209633","article-title":"A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells","volume":"125","author":"Shim","year":"2013","journal-title":"Angew. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01639-8","article-title":"Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor against myocardial ischaemia\u2013reperfusion injury","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0750","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/09540105.2020.1752155","article-title":"Immunochromatographic test strip for the rapid detection of tricaine in fish samples","volume":"31","author":"Lei","year":"2020","journal-title":"Food Agric. Immunol."},{"issue":"13","key":"10.1016\/j.jconrel.2024.07.013_bb0755","doi-asserted-by":"crossref","first-page":"1800103","DOI":"10.1002\/adhm.201800103","article-title":"Reducing bacterial infections and biofilm formation using nanoparticles and nanostructured antibacterial surfaces","volume":"7","author":"Mi","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.461877","article-title":"Development of a simple and reliable high-performance liquid chromatography\u2013tandem mass spectrometry approach to simultaneously detect grains specified in food allergen labeling regulation on processed food commodities","volume":"1639","author":"Seki","year":"2021","journal-title":"J. Chromatogr. A"},{"issue":"7798","key":"10.1016\/j.jconrel.2024.07.013_bb0765","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-020-2066-6","article-title":"Decoy exosomes provide protection against bacterial toxins","volume":"579","author":"Keller","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.013_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1825","article-title":"Cell membrane-coated nanoparticles for the treatment of bacterial infection","volume":"14","author":"Ma","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.013_bb0775","doi-asserted-by":"crossref","first-page":"2006772","DOI":"10.1002\/adma.202006772","article-title":"A dual-responsive antibiotic-loaded nanoparticle specifically binds pathogens and overcomes antimicrobial-resistant infections","volume":"33","author":"Ye","year":"2021","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0780","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.013_bb0785","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/cells11071121","article-title":"Platelets, bacterial adhesins and the pneumococcus","volume":"11","author":"Jahn","year":"2022","journal-title":"Cells"},{"issue":"38","key":"10.1016\/j.jconrel.2024.07.013_bb0790","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.2174\/1381612825666190925163347","article-title":"Crosstalk between platelet and bacteria: a therapeutic prospect","volume":"25","author":"Yadav","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"Pt 2","key":"10.1016\/j.jconrel.2024.07.013_bb0795","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1099\/mic.0.2007\/010868-0","article-title":"Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the \u03b1C-domain of human fibrinogen","volume":"154","author":"Walsh","year":"2008","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0800","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0805","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00018-009-0207-z","article-title":"Platelet\u2013bacterial interactions","volume":"67","author":"Kerrigan","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0810","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2018.06.017","article-title":"\u03b1-Toxin induces platelet aggregation and liver injury during Staphylococcus aureus sepsis","volume":"24","author":"Surewaard","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0815","first-page":"1","article-title":"Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus","volume":"19","author":"Huang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0820","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3389\/fimmu.2019.02204","article-title":"The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0825","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0830","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.thromres.2004.03.023","article-title":"Expression of toll-like receptors on human platelets","volume":"113","author":"Shiraki","year":"2004","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0835","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-\u03b1 production in vivo","volume":"107","author":"Aslam","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01130-w","article-title":"Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing","volume":"19","author":"Peng","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0845","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1203\/00006450-200108000-00002","article-title":"Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome","volume":"50","author":"Proulx","year":"2001","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0850","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbrc.2005.11.008","article-title":"Inhibition of platelet aggregation by anthrax edema toxin","volume":"339","author":"Alam","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0855","doi-asserted-by":"crossref","first-page":"1704800","DOI":"10.1002\/adma.201704800","article-title":"Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats","volume":"30","author":"Li","year":"2018","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.013_bb0860","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.013_bb0865","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.7150\/thno.49781","article-title":"A blood circulation-prolonging peptide anchored biomimetic phage-platelet hybrid nanoparticle system for prolonged blood circulation and optimized anti-bacterial performance","volume":"11","author":"Jin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121790","article-title":"\u201cNanodecoys\u201d-future of drug delivery by encapsulating nanoparticles in natural cell membranes","volume":"621","author":"Imran","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.jconrel.2024.07.013_bb0875","doi-asserted-by":"crossref","first-page":"1706759","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0880","doi-asserted-by":"crossref","first-page":"2006484","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2022.01.004","article-title":"Biomimetic platelet membrane-coated nanoparticles for targeted therapy","volume":"172","author":"Han","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.127296","article-title":"Biomimetic liposomes hybrid with platelet membranes for targeted therapy of atherosclerosis","volume":"408","author":"Song","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0895","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1080\/10717544.2022.2117434","article-title":"Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases","volume":"29","author":"Fang","year":"2022","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0900","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/acs.nanolett.9b02841","article-title":"Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.013_bb0905","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.jconrel.2024.07.013_bb0910","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1039\/D4NR00284A","article-title":"Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy","volume":"16","author":"Zhong","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0915","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","article-title":"Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor","volume":"362","author":"Liu","year":"2023","journal-title":"J. Control. Release"},{"issue":"23\u201324","key":"10.1016\/j.jconrel.2024.07.013_bb0920","doi-asserted-by":"crossref","first-page":"2100153","DOI":"10.1002\/pmic.202100153","article-title":"Targeted liquid chromatography-tandem mass spectrometry analysis of proteins: basic principles, applications, and perspectives","volume":"21","author":"Kulyyassov","year":"2021","journal-title":"Proteomics"},{"issue":"23","key":"10.1016\/j.jconrel.2024.07.013_bb0925","doi-asserted-by":"crossref","first-page":"2101628","DOI":"10.1002\/adhm.202101628","article-title":"Microbubble functionalization with platelet membrane enables targeting and early detection of Sepsis-induced acute kidney injury","volume":"10","author":"Yang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0930","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41565-023-01533-w","article-title":"A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering","volume":"19","author":"Krishnan","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0935","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.594745","article-title":"A rapid intraoperative parathyroid hormone assay based on the immune colloidal gold technique for parathyroid identification in thyroid surgery","volume":"11","author":"Xia","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"32","key":"10.1016\/j.jconrel.2024.07.013_bb0940","doi-asserted-by":"crossref","first-page":"1900795","DOI":"10.1002\/adma.201900795","article-title":"Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0945","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1423-0410.2009.01193.x","article-title":"Pathogen reduction technology (Mirasol\u00ae) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS","volume":"97","author":"Janetzko","year":"2009","journal-title":"Vox Sang."},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.013_bb0950","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1537-2995.2012.03594.x","article-title":"Constant challenges and evolution of US military transfusion medicine and blood operations in combat","volume":"52","author":"Spinella","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jconrel.2024.07.013_bb0955","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1111\/trf.13504","article-title":"Comprehensive review of platelet storage methods for use in the treatment of active hemorrhage","volume":"56","author":"Milford","year":"2016","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.013_bb0960","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOH.0000000000000456","article-title":"Towards increasing shelf life and haemostatic potency of stored platelet concentrates","volume":"25","author":"Hegde","year":"2018","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0965","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.transci.2018.12.011","article-title":"Physiology of cold-stored platelets","volume":"58","author":"Getz","year":"2019","journal-title":"Transfus. Apher. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0970","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.transci.2018.12.012","article-title":"Cold-stored platelets: a product with function optimized for hemorrhage control","volume":"58","author":"Reddoch-Cardenas","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jconrel.2024.07.013_bb0975","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.724525","article-title":"Berberine-loaded biomimetic nanoparticles attenuate inflammation of experimental allergic asthma via enhancing IL-12 expression","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.013_bb0980","first-page":"337","article-title":"Infusible platelet membrane as a platelet substitute for transfusion: an overview","volume":"11","author":"Nasiri","year":"2013","journal-title":"Blood Transfus."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.013_bb0985","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/j.1538-7836.2005.01646.x","article-title":"The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions","volume":"3","author":"Bir\u00f3","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb0990","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jps.23773","article-title":"Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems","volume":"103","author":"Kraft","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.013_bb0995","doi-asserted-by":"crossref","first-page":"11ra22","DOI":"10.1126\/scitranslmed.3000397","article-title":"Synthetic platelets: nanotechnology to halt bleeding","volume":"1","author":"Bertram","year":"2009","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.013_bb1000","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/1535370216647126","article-title":"Platelet-mimetic strategies for modulating the wound environment and inflammatory responses","volume":"241","author":"Nandi","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.013_bb1005","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1038\/s41598-018-21384-z","article-title":"Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve \u2018golden hour\u2019survival in a porcine model of traumatic arterial hemorrhage","volume":"8","author":"Hickman","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:43:58Z","timestamp":1777509838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924004449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":201,"alternative-id":["S0168365924004449"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}